Our thought is GLOBALIZATION

MasoonDarou Pharmaceutical Company (Private Joint Stock Company) was established in 2007 as a knowledge-based company. The company has succeeded in producing biotechnological drugs and vaccines for human consumption by acquiring technical knowledge. It also works by providing new drugs with the help of sophisticated technologies in the field of fighting diseases and promoting the health of the community.

About us

Innovation

Innovation is the key to leadership of Masoondarou

Team working

High-quality products, novel ideas and technologies, all are the outcome of our team efforts.

Quality

The quality of the products are the most important property and counted as the honor of Masoondarou.

Pioneer

Being pioneer at the field of biopharmaceuticals is organizational value in Masoondarou and it’s the only way to go on.

Availability of our products

Masoondarou is the first and only pharmaceutical company in Iran that produces monovalent and polyvalent antitoxins of Clostridium botulinum, Haemophilus influenzae type B conjugate vaccine (MAS-Hib VAC®️) and Clostridium botulinum toxin type A 500 U (MASPORT®️500). The products of Masoondarou Co. were manufactured according to American and European standards. We have high production capacity. In the present time, in addition to fully meeting the needs of the country, the products of Masoondarou Co. have been marketed in Asia, Europe, America, Africa and Oceania, and have been highly welcomed due to their high quality.